Literature DB >> 11081443

Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization.

P Libby1.   

Abstract

Conventional concepts of the pathogenesis of acute coronary syndromes are changing. High-risk lesions are not necessarily the angiographically "tight" stenoses. Rather, unstable vulnerable lesions have large lipid cores and thin fibrous caps. Plaque instability relates closely to the development of inflammation within the intima. Acute coronary syndromes usually result from rupture of a vulnerable atherosclerotic plaque mechanistically linked to the inflammatory process. Stabilization of lesions, rather than percutaneous or surgical procedures, provides a new therapeutic target. Lipid lowering may stabilize lesions by mitigating the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11081443     DOI: 10.1016/s0002-9149(00)01339-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  45 in total

1.  Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease.

Authors:  B J Rollins
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Statins' benefits begin to sprout.

Authors:  D C Altieri
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

3.  So what is critically lacking with coronary atherosclerotic plaques? Perhaps the antithrombotic control.

Authors:  T S Edgington
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Uptake of F-18 FDG and ultrasound analysis of carotid plaque.

Authors:  Yun-Seok Choi; Ho-Joong Youn; Woo-Baek Chung; Hui-Jeong Hwang; Dong-Hyeon Lee; Chul-Soo Park; Jae-Beom Lee; Pum-Joon Kim; Wook-Sung Chung; Man-Young Lee; Kie-Bae Seung; Yong-Ahn Chung
Journal:  J Nucl Cardiol       Date:  2011-01-29       Impact factor: 5.952

Review 5.  Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.

Authors:  Ian S Rogers; Ahmed Tawakol
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

6.  Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.

Authors:  Giovanna Butticè; Janice Miller; Lin Wang; Barbara D Smith
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

7.  Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.

Authors:  Benjamin D Horne; Nicola J Camp; John F Carlquist; Joseph B Muhlestein; Matthew J Kolek; Zachary P Nicholas; Jeffrey L Anderson
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

8.  The melanocortin 1 receptor (MC1R) inhibits the inflammatory response in Raw 264.7 cells and atopic dermatitis (AD) mouse model.

Authors:  Wei Chen; Jianping Li; Hai'e Qu; Zhou Song; Zhanqing Yang; Jinlong Huo; Huaizhi Jiang; Qinghua Huang; Meixia Huo; Bo Liu; Qiaoling Zhang
Journal:  Mol Biol Rep       Date:  2012-10-23       Impact factor: 2.316

9.  Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models.

Authors:  Hailong Huang; Guixue Hu; Chunfeng Wang; Hao Xu; Xiaoqing Chen; Aidong Qian
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

10.  Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease.

Authors:  Benjamin D Horne; John F Carlquist; Joseph B Muhlestein; Tami L Bair; Jeffrey L Anderson
Journal:  Circ Cardiovasc Genet       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.